Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region.

Mol Cell Biol

Molecular Infectious Disease Group, Institute of Molecular Medicine, Oxford University, Oxford, United Kingdom.

Published: December 2000

AI Article Synopsis

  • The NF-kappaB pathway stimulation leads to the presence of p65-p50 and p50-p50 dimers in the cell nucleus, with a specific focus on the TNF promoter region.
  • A natural genetic variation at nucleotide -863 inhibits p50-p50 binding to the NF-kappaB site without affecting p65-p50 binding, impacting gene expression regulation.
  • Findings suggest that p50-p50 can hinder the activity of p65-p50, highlighting how small genetic changes can influence inflammatory gene regulation in humans.

Article Abstract

Stimulation of the NF-kappaB pathway often causes p65-p50 and p50-p50 dimers to be simultaneously present in the cell nucleus. A natural polymorphism at nucleotide -863 in the human TNF promoter (encoding tumor necrosis factor [TNF]) region provides an opportunity to dissect the functional interaction of p65-p50 and p50-p50 at a single NF-kappaB binding site. We found that this site normally binds both p65-p50 and p50-p50, but a single base change specifically inhibits p50-p50 binding. Reporter gene analysis in COS-7 cells expressing both p65-p50 and p50-p50 shows that the ability to bind p50-p50 reduces the enhancer effect of this NF-kappaB site. Using an adenoviral reporter assay, we found that the variant which binds p50-p50 results in a reduction of lipopolysaccharide-inducible gene expression in primary human monocytes. This finding adds to a growing body of experimental evidence that p50-p50 can inhibit the transactivating effects of p65-p50 and illustrates the potential for genetic modulation of inflammatory gene regulation in humans by subtle nucleotide changes that alter the relative binding affinities of different forms of the NF-kappaB complex.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC102169PMC
http://dx.doi.org/10.1128/MCB.20.24.9113-9119.2000DOI Listing

Publication Analysis

Top Keywords

p65-p50 p50-p50
16
p50-p50
9
p50-p50 binding
8
tnf promoter
8
p50-p50 single
8
nf-kappab
5
p65-p50
5
functional consequences
4
consequences polymorphism
4
polymorphism nf-kappab
4

Similar Publications

Background: A water-soluble ingredient of mature leaves of the tropical mahogany 'Neem' (Azadirachta indica), was identified as glycoprotein, thus being named as 'Neem Leaf Glycoprotein' (NLGP). This non-toxic leaf-component regressed cancerous murine tumors (melanoma, carcinoma, sarcoma) recurrently in different experimental circumstances by boosting prime antitumor immune attributes. Such antitumor immunomodulation, aid cytotoxic T cell (T)-based annihilation of tumor cells.

View Article and Find Full Text PDF

SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities.

Front Immunol

October 2020

Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Myeloid-derived suppressor cells (MDSC) are well-known key negative regulators of the immune response during tumor growth, however scattered is the knowledge of their capacity to influence and adapt to the different tumor microenvironments and of the markers that identify those capacities. Here we show that the secreted protein acidic and rich in cysteine (SPARC) identifies in both human and mouse MDSC with immune suppressive capacity and pro-tumoral activities including the induction of epithelial-to-mesenchymal transition (EMT) and angiogenesis. In mice the genetic deletion of SPARC reduced MDSC immune suppression and reverted EMT.

View Article and Find Full Text PDF

M1 and M2 macrophage phenotypes, which mediate proinflammatory and antiinflammatory functions, respectively, represent the extremes of immunoregulatory plasticity in the macrophage population. This plasticity can also result in intermediate macrophage states that support a balance between these opposing functions. In sepsis, M1 macrophages can compensate for hyperinflammation by acquiring an M2-like immunosuppressed status that increases the risk of secondary infection and death.

View Article and Find Full Text PDF

Radiation modulates both tumor cells and immune cells in the tumor microenvironment to exert its anti-tumor activity; however, the molecular connection between tumor cells and immune cells that mediates radiation-exerted tumor suppression activity in the tumor microenvironment is largely unknown. We report here that radiation induces rapid activation of the p65/p50 and p50/p50 NF-κB complexes in human soft tissue sarcoma (STS) cells. Radiation-activated p65/p50 and p50/p50 bind to the TNFα promoter to activate its transcription in STS cells.

View Article and Find Full Text PDF

The NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription.

BMC Cancer

October 2015

Department of Biochemistry and Molecular Biology, Medical College of Georgia, Georgia Regents University, Augusta, GA, 30912, USA.

Background: Inducible nitric oxide synthase (iNOS) metabolizes L-arginine to produce nitric oxide (NO) which was originally identified in myeloid cells as a host defense mechanism against pathogens. Recent studies, however, have revealed that iNOS is often induced in tumor cells and myeloid cells in the tumor microenvironment. Compelling experimental data have shown that iNOS promotes tumor development in certain cellular context and suppresses tumor development in other cellular conditions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!